SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease ; volume:9 ; number:1 ; day:23 ; month:11 ; year:2014 ; pages:1-13 ; date:12.2014
Molecular neurodegeneration ; 9, Heft 1 (23.11.2014), 1-13, 12.2014
- Creator
-
Brinkmalm, Ann
- Contributor
-
Brinkmalm, Gunnar
Honer, William G.
Frölich, Lutz
Hausner, Lucrezia
Minthon, Lennart
Hansson, Oskar
Wallin, Anders
Zetterberg, Henrik
Blennow, Kaj
Öhrfelt, Annika
SpringerLink (Online service)
- DOI
-
10.1186/1750-1326-9-53
- URN
-
urn:nbn:de:1111-2016073075276
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Brinkmalm, Ann
- Brinkmalm, Gunnar
- Honer, William G.
- Frölich, Lutz
- Hausner, Lucrezia
- Minthon, Lennart
- Hansson, Oskar
- Wallin, Anders
- Zetterberg, Henrik
- Blennow, Kaj
- Öhrfelt, Annika
- SpringerLink (Online service)
Other Objects (12)
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease